How Are ADHD Neurons Different in the Brain?
ADHD is linked to subtle but significant differences in brain cell function and communication. Learn about the neurological underpinnings of this condition.
ADHD is linked to subtle but significant differences in brain cell function and communication. Learn about the neurological underpinnings of this condition.
Attention-Deficit/Hyperactivity Disorder (ADHD) is a neurodevelopmental condition characterized by persistent patterns of inattention, hyperactivity, and impulsivity. The brain’s network of nerve cells, or neurons, transmits signals that control thought, feeling, and action. In individuals with ADHD, the communication between these neurons and the circuits they form show subtle but meaningful variations, which helps explain the biological underpinnings of the disorder.
Neurons are the brain’s messengers, transmitting information throughout its network. A neuron consists of a cell body, dendrites that receive signals, and an axon that sends them. Communication occurs at a microscopic gap called a synapse, where the axon releases chemical messengers known as neurotransmitters. These chemicals bind to receptors on the next neuron’s dendrites, continuing the flow of information.
Research into ADHD focuses on two primary neurotransmitters: dopamine and norepinephrine. Dopamine is involved in the brain’s reward system, influencing motivation, pleasure, and focus on goal-oriented tasks. Norepinephrine contributes to alertness, attention, and the body’s stress response. The balance of these chemicals is linked to executive functions like planning and behavior regulation, which are often challenging for individuals with ADHD.
Neuronal communication in a brain with ADHD is often less efficient, not because the neurons are defective, but because of how they manage neurotransmitter signals. A prominent theory suggests the regulation of dopamine and norepinephrine is altered at the synapse. After these chemicals are released, they are cleared away by transporter proteins in a process called reuptake, which prepares the synapse for the next signal.
Research indicates that in ADHD, there can be a high density or efficiency of these transporter proteins, particularly for dopamine. This causes dopamine to be cleared from the synapse too quickly, reducing its ability to stimulate the receiving neuron. The result is a weaker, less consistent signal between neurons, making it difficult to sustain focus on tasks that are not inherently rewarding.
Altered signaling can also involve the receptors on the receiving neuron, which may differ in number or sensitivity. If receptors are less sensitive, a normal amount of neurotransmitter might not be enough to activate the neuron. These disruptions in the release, reuptake, and reception of neurotransmitters lead to dysregulated communication across brain networks, contributing to ADHD symptoms.
Specific brain networks show differences in individuals with ADHD, with imaging studies highlighting variations in the prefrontal cortex, basal ganglia, and cerebellum. These interconnected areas form circuits that regulate attention, behavior, and emotion. The prefrontal cortex is especially relevant as it governs executive functions like planning, decision-making, and impulse control.
Fronto-striatal circuits, which connect the prefrontal cortex with the striatum (part of the basal ganglia), are heavily dependent on dopamine. These pathways manage reward, motivation, and cognitive control. In ADHD, reduced activity and connectivity within these circuits can make it difficult for the prefrontal cortex to filter distractions and sustain attention.
Studies show that in children with ADHD, the prefrontal cortex may mature more slowly, and certain parts can be slightly smaller in volume. Similar size differences have been noted in the hippocampus and amygdala, which are involved in memory and emotional regulation. These structural differences contribute to challenges in executive function and emotional control.
ADHD has a strong genetic component, and research has identified several genes that may contribute to the condition. Many of these genes are involved in regulating dopamine and norepinephrine, such as those that code for transporter proteins or receptors. Variations in these genes can directly influence the efficiency of synaptic communication.
The brain’s development can also differ in individuals with ADHD. During childhood and adolescence, the brain refines its circuits through synaptic pruning (eliminating unused connections) and myelination (speeding up signal transmission). Evidence suggests these processes may be delayed or altered in ADHD, with the maturation of the prefrontal cortex appearing slower. This developmental delay could explain why symptoms often emerge in childhood and may lessen as the brain matures, showing how genetic and developmental factors interact to shape the ADHD brain.
The most common medications for ADHD are stimulants, like methylphenidate and amphetamine-based drugs. These medications work by addressing the neuronal signaling issues, primarily by increasing the availability of dopamine and norepinephrine in the synapse. This action helps compensate for inefficient communication between neurons.
Stimulant medications achieve this by blocking the dopamine and norepinephrine transporter proteins responsible for reuptake. By inhibiting these transporters, the medication allows neurotransmitters to remain in the synapse longer, increasing the chance they will bind to receptors and transmit their signal. Some medications also increase the amount of these neurotransmitters released from the sending neuron.
By enhancing dopamine and norepinephrine levels in brain regions like the prefrontal cortex, these medications help strengthen weakened signals. This improved neuronal communication can enhance focus, reduce impulsivity, and improve executive function. The effectiveness of these drugs further supports the role of these neurotransmitter pathways in ADHD symptoms.